As a specialty, urology has made significant strides in the area of minimallyinvasive surgery. More work needs to be done, however, if urologists canexpect to keep up with patient demand and stay competitive with generalsurgeons, obstetrician-gynecologists, and other specialists.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.